The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Brain Cancer Diagnostics Market Research Report 2025
Synopsis
The global Brain Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Diagnostics.
Report Scope
The Brain Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
GE Healthcare
MDxHealth
NantOmics
Biocept, Inc.
Koninklijke Philips N.V.
Canon Medical Systems
Hitachi, Ltd.
Neusoft Medical Systems
Segment by Type
Imaging Test
Lumbar Puncture
Biopsy
Molecular Testing
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Brain Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Brain Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Cancer Diagnostics.
Report Scope
The Brain Cancer Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Brain Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brain Cancer Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
Siemens Healthineers AG
GE Healthcare
MDxHealth
NantOmics
Biocept, Inc.
Koninklijke Philips N.V.
Canon Medical Systems
Hitachi, Ltd.
Neusoft Medical Systems
Segment by Type
Imaging Test
Lumbar Puncture
Biopsy
Molecular Testing
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Cancer Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brain Cancer Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Imaging Test
1.2.3 Lumbar Puncture
1.2.4 Biopsy
1.2.5 Molecular Testing
1.2.6 Others
1.3 Market by Application
1.3.1 Global Brain Cancer Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brain Cancer Diagnostics Market Perspective (2019-2030)
2.2 Brain Cancer Diagnostics Growth Trends by Region
2.2.1 Global Brain Cancer Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Brain Cancer Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Brain Cancer Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Brain Cancer Diagnostics Market Dynamics
2.3.1 Brain Cancer Diagnostics Industry Trends
2.3.2 Brain Cancer Diagnostics Market Drivers
2.3.3 Brain Cancer Diagnostics Market Challenges
2.3.4 Brain Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brain Cancer Diagnostics Players by Revenue
3.1.1 Global Top Brain Cancer Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Brain Cancer Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Brain Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brain Cancer Diagnostics Revenue
3.4 Global Brain Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Brain Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brain Cancer Diagnostics Revenue in 2023
3.5 Brain Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Brain Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Brain Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brain Cancer Diagnostics Breakdown Data by Type
4.1 Global Brain Cancer Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Brain Cancer Diagnostics Forecasted Market Size by Type (2025-2030)
5 Brain Cancer Diagnostics Breakdown Data by Application
5.1 Global Brain Cancer Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Brain Cancer Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Brain Cancer Diagnostics Market Size (2019-2030)
6.2 North America Brain Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Brain Cancer Diagnostics Market Size by Country (2019-2024)
6.4 North America Brain Cancer Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brain Cancer Diagnostics Market Size (2019-2030)
7.2 Europe Brain Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Brain Cancer Diagnostics Market Size by Country (2019-2024)
7.4 Europe Brain Cancer Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brain Cancer Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Brain Cancer Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Brain Cancer Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Brain Cancer Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brain Cancer Diagnostics Market Size (2019-2030)
9.2 Latin America Brain Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Brain Cancer Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Brain Cancer Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brain Cancer Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Brain Cancer Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Brain Cancer Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Brain Cancer Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Detail
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Siemens Healthineers AG
11.2.1 Siemens Healthineers AG Company Detail
11.2.2 Siemens Healthineers AG Business Overview
11.2.3 Siemens Healthineers AG Brain Cancer Diagnostics Introduction
11.2.4 Siemens Healthineers AG Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.2.5 Siemens Healthineers AG Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Brain Cancer Diagnostics Introduction
11.3.4 GE Healthcare Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.3.5 GE Healthcare Recent Development
11.4 MDxHealth
11.4.1 MDxHealth Company Detail
11.4.2 MDxHealth Business Overview
11.4.3 MDxHealth Brain Cancer Diagnostics Introduction
11.4.4 MDxHealth Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.4.5 MDxHealth Recent Development
11.5 NantOmics
11.5.1 NantOmics Company Detail
11.5.2 NantOmics Business Overview
11.5.3 NantOmics Brain Cancer Diagnostics Introduction
11.5.4 NantOmics Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.5.5 NantOmics Recent Development
11.6 Biocept, Inc.
11.6.1 Biocept, Inc. Company Detail
11.6.2 Biocept, Inc. Business Overview
11.6.3 Biocept, Inc. Brain Cancer Diagnostics Introduction
11.6.4 Biocept, Inc. Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.6.5 Biocept, Inc. Recent Development
11.7 Koninklijke Philips N.V.
11.7.1 Koninklijke Philips N.V. Company Detail
11.7.2 Koninklijke Philips N.V. Business Overview
11.7.3 Koninklijke Philips N.V. Brain Cancer Diagnostics Introduction
11.7.4 Koninklijke Philips N.V. Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.7.5 Koninklijke Philips N.V. Recent Development
11.8 Canon Medical Systems
11.8.1 Canon Medical Systems Company Detail
11.8.2 Canon Medical Systems Business Overview
11.8.3 Canon Medical Systems Brain Cancer Diagnostics Introduction
11.8.4 Canon Medical Systems Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.8.5 Canon Medical Systems Recent Development
11.9 Hitachi, Ltd.
11.9.1 Hitachi, Ltd. Company Detail
11.9.2 Hitachi, Ltd. Business Overview
11.9.3 Hitachi, Ltd. Brain Cancer Diagnostics Introduction
11.9.4 Hitachi, Ltd. Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.9.5 Hitachi, Ltd. Recent Development
11.10 Neusoft Medical Systems
11.10.1 Neusoft Medical Systems Company Detail
11.10.2 Neusoft Medical Systems Business Overview
11.10.3 Neusoft Medical Systems Brain Cancer Diagnostics Introduction
11.10.4 Neusoft Medical Systems Revenue in Brain Cancer Diagnostics Business (2019-2024)
11.10.5 Neusoft Medical Systems Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Brain Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Imaging Test
Table 3. Key Players of Lumbar Puncture
Table 4. Key Players of Biopsy
Table 5. Key Players of Molecular Testing
Table 6. Key Players of Others
Table 7. Global Brain Cancer Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Brain Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Brain Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Brain Cancer Diagnostics Market Share by Region (2019-2024)
Table 11. Global Brain Cancer Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Brain Cancer Diagnostics Market Share by Region (2025-2030)
Table 13. Brain Cancer Diagnostics Market Trends
Table 14. Brain Cancer Diagnostics Market Drivers
Table 15. Brain Cancer Diagnostics Market Challenges
Table 16. Brain Cancer Diagnostics Market Restraints
Table 17. Global Brain Cancer Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Brain Cancer Diagnostics Market Share by Players (2019-2024)
Table 19. Global Top Brain Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Diagnostics as of 2023)
Table 20. Ranking of Global Top Brain Cancer Diagnostics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Brain Cancer Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Brain Cancer Diagnostics Product Solution and Service
Table 24. Date of Enter into Brain Cancer Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Brain Cancer Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Brain Cancer Diagnostics Revenue Market Share by Type (2019-2024)
Table 28. Global Brain Cancer Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Brain Cancer Diagnostics Revenue Market Share by Type (2025-2030)
Table 30. Global Brain Cancer Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Brain Cancer Diagnostics Revenue Market Share by Application (2019-2024)
Table 32. Global Brain Cancer Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Brain Cancer Diagnostics Revenue Market Share by Application (2025-2030)
Table 34. North America Brain Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Brain Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Brain Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Brain Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Brain Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Brain Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Brain Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Brain Cancer Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Brain Cancer Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Brain Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Brain Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Brain Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Brain Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Brain Cancer Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Brain Cancer Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Thermo Fisher Scientific Inc. Company Detail
Table 50. Thermo Fisher Scientific Inc. Business Overview
Table 51. Thermo Fisher Scientific Inc. Brain Cancer Diagnostics Product
Table 52. Thermo Fisher Scientific Inc. Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 53. Thermo Fisher Scientific Inc. Recent Development
Table 54. Siemens Healthineers AG Company Detail
Table 55. Siemens Healthineers AG Business Overview
Table 56. Siemens Healthineers AG Brain Cancer Diagnostics Product
Table 57. Siemens Healthineers AG Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 58. Siemens Healthineers AG Recent Development
Table 59. GE Healthcare Company Detail
Table 60. GE Healthcare Business Overview
Table 61. GE Healthcare Brain Cancer Diagnostics Product
Table 62. GE Healthcare Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 63. GE Healthcare Recent Development
Table 64. MDxHealth Company Detail
Table 65. MDxHealth Business Overview
Table 66. MDxHealth Brain Cancer Diagnostics Product
Table 67. MDxHealth Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 68. MDxHealth Recent Development
Table 69. NantOmics Company Detail
Table 70. NantOmics Business Overview
Table 71. NantOmics Brain Cancer Diagnostics Product
Table 72. NantOmics Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 73. NantOmics Recent Development
Table 74. Biocept, Inc. Company Detail
Table 75. Biocept, Inc. Business Overview
Table 76. Biocept, Inc. Brain Cancer Diagnostics Product
Table 77. Biocept, Inc. Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 78. Biocept, Inc. Recent Development
Table 79. Koninklijke Philips N.V. Company Detail
Table 80. Koninklijke Philips N.V. Business Overview
Table 81. Koninklijke Philips N.V. Brain Cancer Diagnostics Product
Table 82. Koninklijke Philips N.V. Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 83. Koninklijke Philips N.V. Recent Development
Table 84. Canon Medical Systems Company Detail
Table 85. Canon Medical Systems Business Overview
Table 86. Canon Medical Systems Brain Cancer Diagnostics Product
Table 87. Canon Medical Systems Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 88. Canon Medical Systems Recent Development
Table 89. Hitachi, Ltd. Company Detail
Table 90. Hitachi, Ltd. Business Overview
Table 91. Hitachi, Ltd. Brain Cancer Diagnostics Product
Table 92. Hitachi, Ltd. Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 93. Hitachi, Ltd. Recent Development
Table 94. Neusoft Medical Systems Company Detail
Table 95. Neusoft Medical Systems Business Overview
Table 96. Neusoft Medical Systems Brain Cancer Diagnostics Product
Table 97. Neusoft Medical Systems Revenue in Brain Cancer Diagnostics Business (2019-2024) & (US$ Million)
Table 98. Neusoft Medical Systems Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brain Cancer Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Brain Cancer Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. Imaging Test Features
Figure 4. Lumbar Puncture Features
Figure 5. Biopsy Features
Figure 6. Molecular Testing Features
Figure 7. Others Features
Figure 8. Global Brain Cancer Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Brain Cancer Diagnostics Market Share by Application: 2023 VS 2030
Figure 10. Hospitals Case Studies
Figure 11. Specialty Clinics Case Studies
Figure 12. Others Case Studies
Figure 13. Brain Cancer Diagnostics Report Years Considered
Figure 14. Global Brain Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Brain Cancer Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Brain Cancer Diagnostics Market Share by Region: 2023 VS 2030
Figure 17. Global Brain Cancer Diagnostics Market Share by Players in 2023
Figure 18. Global Top Brain Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Cancer Diagnostics as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Brain Cancer Diagnostics Revenue in 2023
Figure 20. North America Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Brain Cancer Diagnostics Market Share by Country (2019-2030)
Figure 22. United States Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Brain Cancer Diagnostics Market Share by Country (2019-2030)
Figure 26. Germany Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Brain Cancer Diagnostics Market Share by Region (2019-2030)
Figure 34. China Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Brain Cancer Diagnostics Market Share by Country (2019-2030)
Figure 42. Mexico Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Brain Cancer Diagnostics Market Share by Country (2019-2030)
Figure 46. Turkey Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Brain Cancer Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Thermo Fisher Scientific Inc. Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 49. Siemens Healthineers AG Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 50. GE Healthcare Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 51. MDxHealth Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 52. NantOmics Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 53. Biocept, Inc. Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 54. Koninklijke Philips N.V. Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 55. Canon Medical Systems Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 56. Hitachi, Ltd. Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 57. Neusoft Medical Systems Revenue Growth Rate in Brain Cancer Diagnostics Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
